[Study on role of natural killer T cells in progression of arteriosclerosis using the mouse model].
Nakai
Yoshihito
Y
D000818:Animals; D018949:Antigens, CD1 / Q000235:genetics / Q000378:metabolism; D055610:Antigens, CD1d; D001057:Apolipoproteins E / Q000235:genetics; D001161:Arteriosclerosis / Q000235:genetics / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D004036:Diet, Atherogenic; D004195:Disease Models, Animal; D005260:Female; D005699:Galactosylceramides; D015329:Gene Rearrangement, T-Lymphocyte; D007694:Killer Cells, Natural / Q000276:immunology*; D008024:Ligands; D008077:Lipoproteins, LDL; D008213:Lymphocyte Activation; D017737:Macrophages, Peritoneal / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D013154:Spleen / Q000378:metabolism
D018949:Antigens, CD1; D055610:Antigens, CD1d; D001057:Apolipoproteins E; D016207:Cytokines; D005699:Galactosylceramides; D008024:Ligands; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein